Role of Prostate Screening in Diagnosing Prostate Cancer

Approximately 1 in 7 men will develop prostate cancer. Over 160,000 new cases of prostate cancer are diagnosed every year. Screening for prostate cancer symptoms can help detect and treat this condition sooner. Keep reading to learn more from the medical professional at the Prostate Cancer Institute.

The Role of Prostate Screening

Just like an annual checkup or mammogram, prostate screening is a procedure that’s designed to look for potential health problems. The ultimate goal of prostate screening is the early detection of prostate cancer. Early detection is essential to developing an effective treatment schedule and increasing your chances of cancer survival. Prostate screening is a relatively new and controversial topic in the medical field, and as of right now, there’s no standard for prostate cancer screening. Researchers are still weighing the benefits of screening, but early clinical trial results suggest that patients who’re screened for prostate cancer have higher chances of surviving it.

Types of Screening

There are two types of prostate screening tests currently available: the digital rectal exam and the prostate-specific antigen test. The digital rectal exam or DRE is a physical and visual exam of the lower rectum. Your doctor or nurse gently probes the prostate by inserting a gloved and lubricated finger into the lower rectum. Like a topical breast exam, a DRE is designed to feel for lumps or abnormal lesions in or around the prostate. The prostate-specific antigen (PSA) test is a blood test that looks for a chemical in the blood that could be a sign of prostate cancer. High levels of prostate antigens are common in men who have developed prostate cancer, but it could also be a sign of prostate infection or benign prostatic hyperplasia.

Screening Eligibility

The American Cancer Society recommends that men over the 50 should see their doctor about prostate screening. African American men and men with a family history of cancer are a higher risk of manifesting prostate cancer symptoms at an earlier age and therefore should consider screening in their 40s. At the Prostate Cancer Institute, Dr. George M. Suarez, creator of the HIFU system, can create a screening and treatment program that’s right for your needs.